Literature DB >> 12907644

Proteomic analysis of intestinal epithelial cells expressing stabilized beta-catenin.

Masahiro Seike1, Tadashi Kondo, Yasuharu Mori, Akihiko Gemma, Shoji Kudoh, Michiie Sakamoto, Tesshi Yamada, Setsuo Hirohashi.   

Abstract

Aberrant accumulation of beta-catenin protein because of mutation of either the beta-catenin or adenomatous polyposis coli gene plays an essential role in the development of colorectal carcinoma. We established previously a stable clone of the rat small intestinal epithelial cell line IEC6, which is capable of inducing stabilized beta-catenin protein lacking NH(2)-terminal glycogen synthase kinase-3beta phosphorylation site under a strict control of the tetracycline-regulatory system. This clone, IEC6-TetOFF-beta-catenin DeltaN89, shows in vitro polypoid growth on the removal of doxycycline and seems to be an appropriate model for analyzing the molecular mechanisms of early intestinal carcinogenesis. Of >2000 protein spots displayed by newly developed two-dimensional difference gel electrophoresis, 22 were found to be up- or down-regulated on the induction of stabilized beta-catenin. The majority of these proteins fell into two categories: (a) redox-status regulatory proteins and (b) cytoskeleton-associated proteins. Representatively, a key redox-status regulatory protein, manganese superoxide dismutase, up-regulated in IEC6 cells expressing stabilized beta-catenin protein, was overexpressed in adenoma and adenocarcinoma cells of familial adenomatous polyposis patients in parallel with the accumulation of beta-catenin. These results suggest that aberrant accumulation of beta-catenin might contribute to colorectal carcinogenesis by affecting redox status in the mitochondria of intestinal epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12907644

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  3 in total

1.  HSP27 modulates epithelial to mesenchymal transition of lung cancer cells in a Smad-independent manner.

Authors:  Hideaki Mizutani; Tetsuya Okano; Yuji Minegishi; Kuniko Matsuda; Junko Sudoh; Kazuhiro Kitamura; Rintaro Noro; Chie Soeno; Akinobu Yoshimura; Masahiro Seike; Akihiko Gemma
Journal:  Oncol Lett       Date:  2010-09-23       Impact factor: 2.967

2.  Anticancer drug clustering based on proteomic profiles and a sensitivity database in a lung cancer cell line panel.

Authors:  Mitsunori Hino; Kuniko Matsuda; Akihiko Miyanaga; Hidehiko Kuribayasi; Hideaki Mizutani; Rintaro Noro; Yuji Minegishi; Tetsuya Okano; Masahiro Seike; Akiko Kawakami; Akinobu Yoshimura; Naoki Ogawa; Haruka Uesaka; Shoji Kudoh; Akihiko Gemma
Journal:  Exp Ther Med       Date:  2010-01-01       Impact factor: 2.447

3.  Identification of haptoglobin peptide as a novel serum biomarker for lung squamous cell carcinoma by serum proteome and peptidome profiling.

Authors:  Tetsuya Okano; Masahiro Seike; Hidehiko Kuribayashi; Chie Soeno; Takeo Ishii; Kozui Kida; Akihiko Gemma
Journal:  Int J Oncol       Date:  2016-01-11       Impact factor: 5.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.